Impact of Polypharmacy on Candidate Biomarker miRNomes for the Diagnosis of Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Striking Back on Treatments. P
Almenar-Perez E et al. (2019) Impact of Polypharmacy on Candidate […]
Almenar-Perez E et al. (2019) Impact of Polypharmacy on Candidate […]
Amsterdam JD et al. (2008) Open-label study of s-citalopram therapy
Arnold LM et al. (2007) Gabapentin in the treatment of
Arnold LM et al. (2015) A Randomized, Placebo-Controlled, Double-Blinded Trial
A Pilot Study of Sertraline for the Treatment of Chronic Fatigue Syndrome. Read More »
Behan PO et al. (1994) A Pilot Study of Sertraline
Russell C et al. (2017) Do evidence-based interventions for chronic
Ryckeghem H et al. (2017) Exploring the potential role of
Sato W (2022) Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Schmaling KB et al. (2005) A longitudinal study of physical
Sharpe M and Greco M (2019) Chronic fatigue syndrome and
Sharpe M et al. (2021) Evidence-Based Care for People with
Shimomura T (2022) Patients with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)
Self-compassion and Adherence in Five Medical Samples: the Role of Stress. Read More »
Sirois FM and Hirsch JK (2019) Self-compassion and Adherence in
Smith MEB et al. (2015) Treatment of Myalgic Encephalomyelitis/Chronic Fatigue
Spencer LH et al. (2023) What interventions or best practice
Evidence for sensitized fatigue pathways in patients with chronic fatigue syndrome. Read More »
Staud R et al. (2015) Evidence for sensitized fatigue pathways
Straub RK & Powers CM (2021) Chronic Fatigue Syndrome: A
Sutcliffe K et al. (2010) Home orthostatic training in chronic
Tan MP et al. (2010) Home orthostatic training in vasovagal
Updated NICE guidance on chronic fatigue syndrome. Read More »
Turner-Stokes L and Wade DT (2020) Updated NICE guidance on